These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1443172)

  • 1. Erythropoietin metabolism and pharmacokinetics in experimental nephrosis.
    Zhou XJ; Vaziri ND
    Am J Physiol; 1992 Nov; 263(5 Pt 2):F812-5. PubMed ID: 1443172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin enhances recovery from cisplatin-induced acute renal failure.
    Vaziri ND; Zhou XJ; Liao SY
    Am J Physiol; 1994 Mar; 266(3 Pt 2):F360-6. PubMed ID: 8160783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin and transferrin metabolism in nephrotic syndrome.
    Vaziri ND
    Am J Kidney Dis; 2001 Jul; 38(1):1-8. PubMed ID: 11431174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of anemia in patients with nephrotic syndrome.
    Shibasaki T; Misawa T; Matsumoto H; Abe S; Nakano H; Matsuda H; Gomi H; Ohno I; Ishimoto F; Sakai O
    Nihon Jinzo Gakkai Shi; 1994 Aug; 36(8):896-901. PubMed ID: 7933664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
    Yoon WH; Park SJ; Kim IC; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentration and urinary excretion of erythropoietin in adult nephrotic syndrome.
    Vaziri ND; Kaupke CJ; Barton CH; Gonzales E
    Am J Med; 1992 Jan; 92(1):35-40. PubMed ID: 1731507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP0463518, a novel inhibitor for hypoxia-inducible factor prolyl hydroxylases, increases erythropoietin in rodents and monkeys with a good pharmacokinetics-pharmacodynamics correlation.
    Kato S; Takayama N; Takano H; Koretsune H; Koizumi C; Kunioka EI; Uchida S; Takahashi T; Yamamoto K
    Eur J Pharmacol; 2018 Nov; 838():138-144. PubMed ID: 30179610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained systemic arterial hypertension induced by extended hypobaric hypoxia.
    Vaziri ND; Wang ZQ
    Kidney Int; 1996 May; 49(5):1457-63. PubMed ID: 8731114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of erythropoietin in liver cirrhosis patients compared with healthy volunteers.
    Jensen JD; Jensen LW; Madsen JK; Poulsen L
    Eur J Haematol; 1995 Feb; 54(2):111-6. PubMed ID: 7698293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma viscosity as a reason for inappropriate erythropoietin formation.
    Singh A; Eckardt KU; Zimmermann A; Götz KH; Hamann M; Ratcliffe PJ; Kurtz A; Reinhart WH
    J Clin Invest; 1993 Jan; 91(1):251-6. PubMed ID: 8423222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin deficiency causes anemia in nephrotic children with normal kidney function.
    Feinstein S; Becker-Cohen R; Algur N; Raveh D; Shalev H; Shvil Y; Frishberg Y
    Am J Kidney Dis; 2001 Apr; 37(4):736-42. PubMed ID: 11273873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression.
    Sun J; Wang Y; Yang J; Du D; Li Z; Wei J; Yang A
    Exp Mol Med; 2012 Nov; 44(11):674-83. PubMed ID: 22990115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in rats.
    Kato M; Okano K; Sakamoto Y; Miura K; Uchimura T; Saito K
    Arzneimittelforschung; 2001 Jan; 51(1):91-5. PubMed ID: 11215332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin production by the kidney and the liver in response to severe hypoxia evaluated by Western blotting with deglycosylation.
    Yasuoka Y; Fukuyama T; Izumi Y; Nakayama Y; Inoue H; Yanagita K; Oshima T; Yamazaki T; Uematsu T; Kobayashi N; Shimada Y; Nagaba Y; Mukoyama M; Yamashita T; Sato Y; Sands JM; Kawahara K; Nonoguchi H
    Physiol Rep; 2020 Jun; 8(12):e14485. PubMed ID: 32592328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin response to acute hypobaric or anaemic hypoxia in gentamicin-administered rats.
    Shimizu S; Enoki Y; Sakata S; Kohzuki H; Ohga Y; Matsumura K
    Acta Physiol Scand; 1994 Jun; 151(2):225-31. PubMed ID: 7942058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endogenous erythropoietin response and the erythropoietic response to blood loss anemia: the effects of age and gender.
    Goodnough LT; Price TH; Parvin CA
    J Lab Clin Med; 1995 Jul; 126(1):57-64. PubMed ID: 7602235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected hypoxia-dependent erythropoietin secretion during experimental conditions not affecting tissue oxygen supply/demand ratio.
    Bozzini CE; Barceló AC; Conti MI; Martínez MP; Lezón CE; Bozzini C; Alippi RM
    Kidney Int; 1997 Feb; 51(2):413-5. PubMed ID: 9027714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catabolism of very low density lipoproteins in experimental nephrosis.
    Garber DW; Gottlieb BA; Marsh JB; Sparks CE
    J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aging on erythropoietin secretion in male rats.
    Wang RY; Tsai SC; Lu CC; Shih HC; Chen YH; Tung YF; Wang WF; Wang SW; Wang PS
    J Gerontol A Biol Sci Med Sci; 1996 Nov; 51(6):B434-8. PubMed ID: 8914493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ distribution of erythropoietin messenger RNA in normal and uremic rats.
    Tan CC; Eckardt KU; Ratcliffe PJ
    Kidney Int; 1991 Jul; 40(1):69-76. PubMed ID: 1921157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.